Lung Cancer Screening Protocol

Not Applicable

Completed

• Conditions: Lung Cancer Screening
• Interventions: Other: Toolbox for Lung Cancer Screening

• Registration Number: NCT03958253
• Lead Sponsor: Washington University School of Medicine

Brief Summary

The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2019-04-22
• Study First Submitted: 2019-05-17
• Study First Submitted QC: 2019-05-17
• Study First Posted: 2019-05-21
• Primary Completion: 2021-03-31
• Study Completion: 2021-03-31
• Status Verified: 2021-04
• Last Update Submitted: 2021-04-06
• Last Update Posted: 2021-04-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 193

Inclusion Criteria

• To be eligible to participate in the trial, screening centers have to be existing members of the BJC Collaborative.
• Primary Care Providers have to have a referral relationship with the screening center; serve adult patients who may be screening-eligible, and are willing to interact with the referral site to implement referral for LDCT.

Read More

Exclusion Criteria

There are not any exclusion criteria for the study

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SEQUENTIAL

Arm && Interventions

Group	Intervention	Description
Lung Cancer Screening Toolbox	Toolbox for Lung Cancer Screening	* WU Staff will train local screening staff using a train-the-trainer model three months prior to the intervention and will provide technical assistance on an ongoing basis. * During the 3 hour train-the-trainer session, the selected staff from the referral sites will learn about the program, receive an orientation to the toolbox elements, and discuss how to adapt the elements of the toolbox to their referral sites.

Primary Outcome Measures

Name	Time	Method
Number of initial low-dose CT (LDCT) scan screenings per month per screening center	Completion of study (estimated to be 21 months)	-Screening will be defined as completed initial screen for lung cancer

Secondary Outcome Measures

Name	Time	Method
Number of primary care providers who refer at least two patients per month for LDCT	Completion of study (estimated to be 21 months)
Percent of patients referred who are screen-eligible	Completion of study (estimated to be 21 months)	Defined as the number of screen-eligible patients divided by the total of screening procedures performed
Percent of patients referred who complete screening	Completion of study (estimated to be 21 months)	Defined as the number of patients referred for screening divided by the total number of screening procedures performed.

Trial Locations

Locations (7)

Decatur Memorial Hospital; 🇺🇸 Decatur, Illinois, United States

CoxHealth; 🇺🇸 Springfield, Missouri, United States

BJC HealthCare, Barnes-Jewish St. Peters Hospital; 🇺🇸 Saint Peters, Missouri, United States

Washington University School of Medicine; 🇺🇸 Saint Louis, Missouri, United States

Southern Illinois Healthcare; 🇺🇸 Carbondale, Illinois, United States

Sarah Bush Lincoln Health System; 🇺🇸 Mattoon, Illinois, United States

Memorial Health System; 🇺🇸 Springfield, Illinois, United States